|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 120.20 PLN | +0.17% |
|
+1.52% | -11.75% |
| 05-27 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| 05-15 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 27.83K | -46,364% | -47,282% | -30.03% | -25.14% | 2.86x | ||
| 517M | 12.83% | 11.17% | 11.52% | - | -2.9x | ||
| 277M | -21.48% | -20.62% | -27.84% | -11.31% | -8.26x | ||
| 264M | -148.38% | -153.08% | -55.5% | - | 0.83x | ||
| 380M | -5.62% | -8.1% | - | - | - | ||
| 186M | -70.41% | -44.52% | -57.13% | -14.7% | -2.4x | ||
| 329M | 10.18% | 7.29% | 4.81% | 3.94% | -2.66x | ||
| 4.06M | -1,238.52% | -1,260.76% | - | - | - | ||
| 15.13M | -42.34% | -47% | -26.44% | -18.06% | - | ||
| 123M | -14.88% | 11.93% | - | - | -0.78x | ||
| Average | 209M | -4,788.26% | -4,878.57% | -25.8% | -13.06% | -1.90x | |
| Weighted average by Cap. | 356M | -390.95% | -397.8% | -16.97% | -9.74% | -3.71x |
- Stock Market
- Stocks
- SCP Stock
- Sector Scope Fluidics S.A.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
















